Amazon Pharmacy adds Wegovy pill to weight-loss offering

THE WHAT? Amazon Pharmacy has begun offering Novo Nordisk’s oral Wegovy weight-loss treatment, expanding access to the newly approved GLP-1 tablet in the US.

THE DETAILS Customers with commercial insurance will pay a minimum of US$25 for a one-month supply, while self-pay pricing starts at US$149 per month. The once-daily pill was approved by the US Food and Drug Administration last month and is now available through tens of thousands of pharmacies and telehealth platforms nationwide.

THE WHY? The move highlights intensifying competition in the GLP-1 market as oral formulations enter distribution alongside injectables. Lower entry pricing and pill-based delivery could broaden adoption among cost-conscious and needle-averse consumers, with implications for wellness, weight management and adjacent consumer health categories.

Source: The Wall Street Journal

The post Amazon Pharmacy adds Wegovy pill to weight-loss offering appeared first on Global Cosmetics News.